Hughes Owen — SEC Form 4 filings
SEC reporting owner CIK 1575933. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-10 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 100,000 shares, $2,505,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 47,518 shares, $1,306,003 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: purchase of 100,000 shares @ $25.05 ($2,505,000) in XOMA Royalty Corp, filed 2025-12-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| XOMA Royalty Corp (XOMA) | Chief Executive Officer, Director | 8 | 1 leg · 100,000 sh · $2,505,000 | 2 legs · 47,518 sh · $1,306,003 | 18 |
| C4 Therapeutics, Inc. (CCCC) | Director | 3 | — | — | 3 |
| ANAPTYSBIO, INC (ANAB) | Director | 1 | — | — | 1 |
| Ikena Oncology, Inc. (IKNA) | Director | 1 | — | — | 1 |
Form 4 filings — Hughes Owen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-14 | 4 | XOMA Royalty Corp (XOMA) | Other (J): 191,264 · Other (J): 752 · Disposition to issuer (D): 102,000 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 75,000 (derivative) @ $0 · Disposition to issuer (D): 116,245 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-26 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 62,000 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 11,250 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | XOMA Royalty Corp (XOMA) | Option exercise (M): 10,568 @ $0 · Option exercise (M): 10,568 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | XOMA Royalty Corp (XOMA) | Grant/award (A): 82,428 @ $0 · Grant/award (A): 126,813 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | XOMA Royalty Corp (XOMA) | Purchase (P): 100,000 @ $25.05 | EDGAR |
| 2025-09-23 | 4 | XOMA Royalty Corp (XOMA) | Option exercise (M): 35,567 @ $0 · Option exercise (M): 35,567 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 35,500 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | XOMA Royalty Corp (XOMA) | Option exercise (M): 53,359 @ $0 · Sale (S): 25,637 @ $25.38 · Option exercise (M): 53,359 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | XOMA Royalty Corp (XOMA) | Option exercise (M): 53,360 @ $0 · Sale (S): 21,881 @ $29.95 · Option exercise (M): 53,360 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 17,520 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | XOMA Corp (XOMA) | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1575933 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →